17-Heteroaroyl esters of corticosteroids. 2. 11 beta-Hydroxy series

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Dermatology

Background:

• Corticosteroids are widely used for their anti-inflammatory properties.
• Development of novel corticosteroids with improved potency and topical activity is an ongoing area of research.
• Heterocyclic esters of corticosteroids offer potential for enhanced therapeutic profiles.

Purpose of the Study:

• To synthesize and evaluate the topical anti-inflammatory potencies of novel corticosteroid esters.
• To investigate the structure-activity relationships of 17-furoyl and -thenoyl esters of specific corticosteroid derivatives.
• To identify potent topical anti-inflammatory agents for potential clinical use.

Main Methods:

• Synthesis of 17-furoyl and -thenoyl esters of 9 alpha-fluoro-11 beta-hydroxy-16 methyl and 9 alpha-chloro-11 beta-hydroxy-16-methyl corticosteroids.
• Introduction of 17 alpha-esters via direct acylation using heteroaryl carbonyl chlorides and 4-(dimethylamino)pyridine.
• Evaluation of anti-inflammatory potency in mice using a modified Tonelli croton oil ear assay.
• Clinical evaluation of promising candidates in human subjects.

Main Results:

• Several novel corticosteroid esters were successfully synthesized and characterized.
• Compounds 1e (dexamethasone 17-(2'-furoate) 21-propionate) and 2c (9 alpha-chloro-17-(2'-furoate) 21-chloro) exhibited the highest potency, being 6 times more effective than betamethasone 17-valerate in the mouse ear assay.
• Other 9 alpha-chloro-11 beta-hydroxy-17-heteroaryl carboxylates also showed significant anti-inflammatory activity (at least 4 times that of betamethasone 17-valerate).
• Clinical studies confirmed the potent topical anti-inflammatory activity of compound 2c in humans.

Conclusions:

• Novel 17-furoyl and -thenoyl corticosteroid esters represent a promising class of topical anti-inflammatory agents.
• Compounds 1e and 2c demonstrate superior potency compared to a standard corticosteroid.
• The findings support the potential clinical utility of these novel corticosteroids for treating inflammatory skin conditions.